Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center Study to Assess the Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer

NCT06122584 is registered in ClinicalTrials.gov with ABX advanced biochemical compounds GmbH as lead sponsor.

NCT NCT06122584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06122584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center Study to Assess the Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer
Lead sponsor
ABX advanced biochemical compounds GmbH
Phase
Phase 3
Overall status
Recruiting
Start date
June 13, 2024
Completion date
September 30, 2027
Enrollment
380 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer